title: Vertebral augmentation and the limits of interpreting complications reported in the food and drug administration manufacturer and user facility device experience database.
authors.affiliation: Department of Orthopaedic Surgery, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. lieberi@ccf.org
authors.forename: Isador H
authors.initials: IH
authors.lastname: Lieberman
authors.forename: Frank M
authors.initials: FM
authors.lastname: Phillips
authors.forename: Daisuke
authors.initials: D
authors.lastname: Togawa
authors.forename: Michael
authors.initials: M
authors.lastname: Modic
authors.forename: Thomas
authors.initials: T
authors.lastname: Masaryk
authors.forename: Nancy
authors.initials: N
authors.lastname: Obuchowski
authors.forename: Curtis W
authors.initials: CW
authors.lastname: Slipman
mesh_terms: D022126:Access to Information; D001416:Back Pain / Q000209:etiology / Q000517:prevention & control; D001843:Bone Cements / Q000009:adverse effects / Q000627:therapeutic use; D016208:Databases, Factual; D004864:Equipment and Supplies; D005593:Fracture Fixation, Internal / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D007738:Kyphosis / Q000628:therapy; D009862:Online Systems; D019904:Polymethyl Methacrylate / Q000009:adverse effects / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology; D016103:Spinal Fractures / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001843:Bone Cements; D019904:Polymethyl Methacrylate